CG Oncology Ownership | Who Owns CG Oncology?


OverviewForecastRevenueFinancialsChart

CG Oncology Ownership Summary


CG Oncology is owned by 111.69% institutional investors, 0.23% insiders. Rtw investments, lp is the largest institutional shareholder, holding 10.07% of CGON shares. Vanguard Health Care Inv is the top mutual fund, with 3.24% of its assets in CG Oncology shares.

CGON Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCG Oncology111.69%0.23%-11.92%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp8.51M10.07%$604.96M
Vanguard group6.54M8.52%$271.52M
T. rowe price investment management6.62M7.83%$470.13M
Decheng capital6.37M7.54%$452.71M
Blackrock funding, inc. /de6.26M7.40%$444.51M
Wellington management group llp5.32M6.30%$378.32M
Fmr4.16M4.92%$295.67M
Price t rowe associates inc /md/3.81M4.50%$270.35M
Tcg crossover management3.67M4.34%$260.77M
State street3.44M4.07%$244.24M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Decheng capital6.37M61.87%$452.71M
Foresite capital management vi2.37M26.20%$168.36M
Acorn capital advisors1.13M21.94%$80.39M
Foresite capital management v1.08M21.17%$76.67M
Avidity partners management lp1.40M15.92%$99.40M
Tcg crossover management3.67M6.27%$260.77M
Rtw investments, lp8.51M5.16%$604.96M
Ecor1 capital1.49M5.16%$106.17M
Saturn v capital management579.89K5.12%$23.36M
Dv trading1.44M3.35%$102.27M

Top Buyers

HolderShares% AssetsChange
Rtw investments, lp8.51M5.16%1.53M
Blackrock funding, inc. /de6.26M0.01%1.19M
Sg americas securities867.47K0.03%842.83K
State street3.44M0.01%790.54K
American century companies726.15K0.02%721.25K

Top Sellers

HolderShares% AssetsChange
Driehaus capital management---999.62K
Braidwell lp---984.78K
Kynam capital management, lp---945.83K
Deerfield management company, l.p. (series c)---850.70K
Frazier life sciences management---770.00K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company627.18K0.01%627.18K$44.56M
Toronto dominion bank287.63K0.02%287.63K$20.44M
Vestal point capital, lp175.00K0.32%175.00K$7.05M
Alyeska investment group61.73K0.01%61.73K$4.39M
Man group51.85K0.01%51.85K$3.68M

Sold Out

HolderChange
Advisornet financial-2.00
Twin peaks wealth advisors-2.00
Root financial partners-2.00
Advisory services network-5.00
Parallel advisors-11.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026244-0.81%94,396,7077.11%1110.86%131-11.49%7620.63%
Mar 31, 202624118.14%85,156,8713.05%1100.95%14522.88%6224.00%
Dec 31, 202545-75.27%11,870,229-84.71%150.15%21-76.40%16-72.88%
Sep 30, 202559-64.88%10,389,844-86.31%130.14%25-78.63%20-28.57%
Jun 30, 202516716.78%75,899,2598.77%991.19%11631.82%28-15.15%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Health Care Inv2.86M3.24%-72.42K
T. Rowe Price Capital Appreciation2.54M2.88%2.54M
Vanguard MStar Total Stk Mkt Idx Invest2.39M2.71%8.33K
Vanguard Morn Total Stk Mkt Idx Investor2.38M2.70%190.05K
Vanguard Total Stock Mkt Idx Inv2.38M2.70%190.05K
iShares Russell 2000 ETF1.87M2.11%-33.12K
State Street® SPDR® S&P® Biotech ETF1.78M2.02%4.09K
Vanguard Small Cap Index1.72M1.95%4.47K
US Small-Cap Growth II Equity Comp1.11M1.26%372.37K
T. Rowe Price New Horizons1.11M1.26%372.70K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 14, 2026POST LEONARD E-Sell$74.54K
Jul 15, 2026POST LEONARD E-Sell$71.17K
Jul 10, 2026Mulay James-Sell$1.82M
Jun 25, 2026Liu Brian Guan-Chyun-Buy$24.81M
Jun 24, 2026POST LEONARD E-Sell$350.00K

Insider Transactions Trends


DateBuySell
2026 Q3-2
2026 Q215
2026 Q1-3
2025 Q4-3
2025 Q3115

CGON Ownership FAQ


Who Owns CG Oncology?

CG Oncology shareholders are primarily institutional investors at 111.69%, followed by 0.23% insiders and -11.92% retail investors. The average institutional ownership in CG Oncology's industry, Biotech Stocks , is 379.61%, which CG Oncology falls below.

Who owns the most shares of CG Oncology?

CG Oncology’s largest shareholders are Rtw investments, lp (8.51M shares, 10.07%), Vanguard group (6.54M shares, 8.52%), and T. rowe price investment management (6.62M shares, 7.83%). Together, they hold 26.43% of CG Oncology’s total shares outstanding.

Does Blackrock own CG Oncology?

BlackRock is not among the top 10 institutional shareholders of CG Oncology.

Who is CG Oncology’s biggest shareholder by percentage of total assets invested?

Decheng capital is CG Oncology’s biggest shareholder by percentage of total assets invested, with 61.87% of its assets in 6.37M CG Oncology shares, valued at 452.71M$.

Who is the top mutual fund holder of CG Oncology shares?

Vanguard Health Care Inv is the top mutual fund holder of CG Oncology shares, with 3.24% of its total shares outstanding invested in 2.86M CG Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools